Below are the most recent publications written about "Muscular Dystrophy, Duchenne" by people in Profiles.
-
Saylam E, D'ambrosio ES, Pesco MT, Gushchina LV. Adeno-Associated Virus Toxicity in Duchenne Muscular Dystrophy: Mechanisms and Clinical Considerations. Genes (Basel). 2026 Feb 27; 17(3).
-
Falk EN, Chrzanowski SM, Coyne F, Sheldon Y, Cherkerzian S, Parad RB. Interpreting Neonatal hyperCKemia Identified Through Duchenne Muscular Dystrophy Newborn Screening: A Predictive Model Based on Maternal, Labor, Delivery and Newborn Factors. Muscle Nerve. 2026 Mar; 73(3):459-470.
-
Rosenthal DN, Amodeo A, Butterfield RJ, Butts R, Chrzanowski S, Cripe L, Day J, Davies R, Duong T, Evers P, Gambetta K, Harris R, Hayes E, Kaufman B, Lorts A, Mack G, Mackenzie SJ, Mammen P, Markham L, McAlister J, McDonald C, Nakano SJ, Nandi D, Navaratnam M, Nelson S, Parent JJ, Piccoli C, Richmond M, Rocha C, Sawnani H, Schrader R, Shell R, Shih R, Shugh S, Smart T, Soslow J, Spinner J, Taivassalo T, Tunugtla H, VanderPluym C, Veerapandiyan A, Villa C, Wittlieb-Weber C, Zafarullah M, Hollander S. Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era. Pediatr Transplant. 2026 01; 30(1):e70253.
-
Groenwold ET, Montulet A, Stan T, van de Vijver D, McCorquodale D, McHugh N, Echeverria D, Winter CT, van de Wal M, O'Reilly D, Khvorova A, Aartsma-Rus A, Damha MJ. Conjugated Antisense Oligonucleotides for Skipping of Duchenne Muscular Dystrophy Exon 53: A Cautionary Study. Nucleic Acid Ther. 2026 Apr; 36(2):100-108.
-
Chrzanowski S, D'Ambrosio ES. The Essential Role of Medicaid in Duchenne Muscular Dystrophy Care: A Call to Protect Vulnerable Populations. Pediatr Neurol. 2025 Aug; 169:91-92.
-
Hern?ndez Rodr?guez MY, Biswas DD, Slyne AD, Lee J, Scarrow E, Abdelbarr SM, Daniels H, O'Halloran KD, Ferreira LF, Gersbach CA, ElMallah MK. Respiratory pathology in the mdx/utrn -/- mouse: A murine model for Duchenne Muscular Dystrophy (DMD). PLoS One. 2025; 20(2):e0316295.
-
Susorov D, Echeverria D, Khvorova A, Korostelev AA. mRNA-specific readthrough of nonsense codons by antisense oligonucleotides (R-ASOs). Nucleic Acids Res. 2024 08 27; 52(15):8687-8701.
-
Roger AL, Biswas DD, Huston ML, Le D, Bailey AM, Pucci LA, Shi Y, Robinson-Hamm J, Gersbach CA, ElMallah MK. Respiratory characterization of a humanized Duchenne muscular dystrophy mouse model. Respir Physiol Neurobiol. 2024 08; 326:104282.
-
Hart CC, Lee YI, Xie J, Gao G, Lin BL, Hammers DW, Sweeney HL. Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy. JCI Insight. 2024 05 07; 9(11).
-
Chrzanowski S, Batra R. CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders. Pediatr Neurol. 2024 Apr; 153:166-174.